69 related articles for article (PubMed ID: 17514685)
1. Valsartan reverses post-translational modifications of the delta-subunit of ATP synthase during in vivo canine reperfused myocardial infarction.
Sawicki G; Jugdutt BI
Proteomics; 2007 Jun; 7(12):2100-10. PubMed ID: 17514685
[TBL] [Abstract][Full Text] [Related]
2. AT1 receptor blockade alters metabolic, functional and structural proteins after reperfused myocardial infarction: detection using proteomics.
Jugdutt BI; Sawicki G
Mol Cell Biochem; 2004 Aug; 263(1-2):179-88. PubMed ID: 15524179
[TBL] [Abstract][Full Text] [Related]
3. Valsartan-induced cardioprotection involves angiotensin II type 2 receptor upregulation in dog and rat models of in vivo reperfused myocardial infarction.
Jugdutt BI; Menon V
J Card Fail; 2004 Feb; 10(1):74-82. PubMed ID: 14966778
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of angiotensin II type 2 receptor and limitation of myocardial stunning by angiotensin II type 1 receptor blockers during reperfused myocardial infarction in the rat.
Jugdutt BI; Menon V
J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):217-26. PubMed ID: 14506547
[TBL] [Abstract][Full Text] [Related]
5. AT1 receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction.
Jugdutt BI; Menon V
Mol Cell Biochem; 2004 May; 260(1-2):111-8. PubMed ID: 15228092
[TBL] [Abstract][Full Text] [Related]
6. AT1receptor blockade alters metabolic, functional and structural proteins after reperfused myocardial infarction: Detection using proteomics.
Jugdutt BI; Sawicki G
Mol Cell Biochem; 2004 Aug; 263(1):179-88. PubMed ID: 27520677
[TBL] [Abstract][Full Text] [Related]
7. Improved balance between TIMP-3 and MMP-9 after regional myocardial ischemia-reperfusion during AT1 receptor blockade.
Sawicki G; Menon V; Jugdutt BI
J Card Fail; 2004 Oct; 10(5):442-9. PubMed ID: 15470656
[TBL] [Abstract][Full Text] [Related]
8. Aging-related early changes in markers of ventricular and matrix remodeling after reperfused ST-segment elevation myocardial infarction in the canine model: effect of early therapy with an angiotensin II type 1 receptor blocker.
Jugdutt BI; Jelani A; Palaniyappan A; Idikio H; Uweira RE; Menon V; Jugdutt CE
Circulation; 2010 Jul; 122(4):341-51. PubMed ID: 20625108
[TBL] [Abstract][Full Text] [Related]
9. Valsartan therapy in heart failure after myocardial infarction: the role of endothelial dependent vasorelaxation.
Thai H; Guarraia D; Johnson N; Goldman S; Gaballa MA
J Cardiovasc Pharmacol; 2007 Dec; 50(6):703-7. PubMed ID: 18091589
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
[TBL] [Abstract][Full Text] [Related]
11. Valsartan, captopril, or both in myocardial infarction.
McAnulty JH
N Engl J Med; 2004 Feb; 350(9):943-5; author reply 943-5. PubMed ID: 14985495
[No Abstract] [Full Text] [Related]
12. Interventional effect of valsartan on expression of inducible cAMP early repressor and phosphodiesterase 3A in rats after myocardial infarction.
Ma D; Fu L; Shen J; Zhou P; Gao Y; Xie R; Li Y; Han Y; Wang Y; Wang F
Eur J Pharmacol; 2009 Jan; 602(2-3):348-54. PubMed ID: 19027736
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective role of angiotensin II type 2 receptor after transient focal ischemia in mice brain.
Miyamoto N; Zhang N; Tanaka R; Liu M; Hattori N; Urabe T
Neurosci Res; 2008 Jul; 61(3):249-56. PubMed ID: 18455256
[TBL] [Abstract][Full Text] [Related]
14. Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signalling.
Su KH; Tsai JY; Kou YR; Chiang AN; Hsiao SH; Wu YL; Hou HH; Pan CC; Shyue SK; Lee TS
Cardiovasc Res; 2009 Jun; 82(3):468-75. PubMed ID: 19307231
[TBL] [Abstract][Full Text] [Related]
15. Improvement of stunned myocardium in dogs with olmesartan, an angiotensin II type 1 receptor antagonist, is independent of type 2 receptors.
Kano S; Satoh K; Kaneta S; Ichihara K
Pharmacology; 2008; 82(1):22-9. PubMed ID: 18434761
[TBL] [Abstract][Full Text] [Related]
16. Insulin inhibits beta-adrenergic action in ischemic/reperfused heart: a novel mechanism of insulin in cardioprotection.
Yu QJ; Si R; Zhou N; Zhang HF; Guo WY; Wang HC; Gao F
Apoptosis; 2008 Feb; 13(2):305-17. PubMed ID: 18165901
[TBL] [Abstract][Full Text] [Related]
17. [Effect of cilazapril and valsartan on the levels of cardiac interstitial water content in rats with acute myocardial infarction].
Sun J; Zhang SS; Mao YM; Sun GY; Zhao HM; Liu GQ; Cui RZ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Apr; 19(4):244-5. PubMed ID: 17448284
[No Abstract] [Full Text] [Related]
18. Valsartan improves mitochondrial function in hearts submitted to acute ischemia.
Monteiro P; Duarte AI; Gonçalves LM; Providência LA
Eur J Pharmacol; 2005 Aug; 518(2-3):158-64. PubMed ID: 16055115
[TBL] [Abstract][Full Text] [Related]
19. Effect of valsartan on the expression of angiotensin II receptors in the lung of chronic antigen exposure rats.
Wang T; Yin KS; Liu KY; Lu GJ; Li YH; Chen JD
Chin Med J (Engl); 2008 Nov; 121(22):2312-9. PubMed ID: 19080339
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II receptor blocker inhibits tumour necrosis factor-alpha-induced cell damage in human renal proximal tubular epithelial cells.
Kagawa T; Takao T; Horino T; Matsumoto R; Inoue K; Morita T; Hashimoto K
Nephrology (Carlton); 2008 Jun; 13(4):309-15. PubMed ID: 18331441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
